Simon Quick Advisors LLC Boosts Stake in Intuitive Surgical, Inc. $ISRG

Simon Quick Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 84.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 4,546 shares of the medical equipment provider’s stock after purchasing an additional 2,080 shares during the period. Simon Quick Advisors LLC’s holdings in Intuitive Surgical were worth $2,470,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $26,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. 1248 Management LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. HSBC upped their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Argus upped their price objective on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Finally, The Goldman Sachs Group upped their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Trading Down 1.4%

Shares of ISRG stock opened at $530.02 on Friday. The company has a market cap of $190.00 billion, a price-to-earnings ratio of 70.11, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The stock has a 50 day simple moving average of $463.16 and a 200-day simple moving average of $498.23. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the sale, the executive vice president owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 96,011 shares of company stock worth $50,309,042. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.